Solvay Animal Health, Inc., et al.; Withdrawal of Approval of NADA's

Resumen

The Food and Drug Administration (FDA) is withdrawing approval of two new animal drug applications (NADA's). One NADA is held by Solvay Animal Health, Inc., and provides for the use of a sulfaquinoxaline soluble powder. The other NADA is held by Pharmachem Corp. and provides for the use of a dextran injection. The sponsors requested withdrawal of approval of the NADA's because they no longer manufacture or distribute the products.